StockData
Novartis AG logo

Novartis AG (NVS) stock

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.20−0.30 (-0.19%)

Close on Nov 16, 2026Market cap $305.69BP/E 22.4Yield –

Novartis market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Novartis's market cap was $319.17B on Nov 10, 2026, against $265.36B a year earlier. Over the last 5 years it ranged from $171.78B to $321.75B, with a median of $220.75B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$319.17B+13.8%
2025Dec 31, 2025$280.57B+37.8%
2024Dec 31, 2024$203.57B-8.2%
2023Dec 29, 2023$221.83B+8.2%
2022Dec 30, 2022$205.03B+2.1%
2021Dec 31, 2021$200.83B-8.3%
2020Dec 31, 2020$218.98B-1.3%
2019Dec 31, 2019$221.95B+11.4%
2018Dec 31, 2018$199.23B-0.0%
2017Dec 29, 2017$199.33B+15.3%
2016Dec 30, 2016$172.91B-16.2%
2015Dec 31, 2015$206.38B–

More Novartis figures

See a number that looks wrong?